- Home
- PGEN vs AGL Comparison
PGEN vs AGL Comparison
Compare PGEN & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- AGL
- Stock Information
- Founded
- PGEN 1998
- AGL 2016
- Country
- PGEN United States
- AGL United States
- Employees
- PGEN N/A
- AGL N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- AGL Managed Health Care
- Sector
- PGEN Health Care
- AGL Health Care
- Exchange
- PGEN Nasdaq
- AGL Nasdaq
- Market Cap
- PGEN 493.0M
- AGL 443.4M
- IPO Year
- PGEN N/A
- AGL 2021
- Fundamental
- Price
- PGEN $3.28
- AGL $1.07
- Analyst Decision
- PGEN Buy
- AGL Hold
- Analyst Count
- PGEN 5
- AGL 20
- Target Price
- PGEN $7.50
- AGL $2.75
- AVG Volume (30 Days)
- PGEN 5.8M
- AGL 6.2M
- Earning Date
- PGEN 11-13-2025
- AGL 11-04-2025
- Dividend Yield
- PGEN N/A
- AGL N/A
- EPS Growth
- PGEN N/A
- AGL N/A
- EPS
- PGEN N/A
- AGL N/A
- Revenue
- PGEN $4,340,000.00
- AGL $5,901,182,000.00
- Revenue This Year
- PGEN $249.10
- AGL N/A
- Revenue Next Year
- PGEN $710.03
- AGL $6.21
- P/E Ratio
- PGEN N/A
- AGL N/A
- Revenue Growth
- PGEN N/A
- AGL 11.76
- 52 Week Low
- PGEN $0.65
- AGL $0.71
- 52 Week High
- PGEN $5.23
- AGL $6.08
- Technical
- Relative Strength Index (RSI)
- PGEN 46.00
- AGL 40.92
- Support Level
- PGEN $3.37
- AGL $1.11
- Resistance Level
- PGEN $4.00
- AGL $1.18
- Average True Range (ATR)
- PGEN 0.25
- AGL 0.07
- MACD
- PGEN -0.12
- AGL 0.01
- Stochastic Oscillator
- PGEN 21.08
- AGL 25.00
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.